BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3115493)

  • 1. Influence of non-steroidal anti-inflammatory drugs in faecal occult blood tests.
    Niv Y
    Br Med J (Clin Res Ed); 1987 Aug; 295(6595):446. PubMed ID: 3115493
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer.
    Pye G; Ballantyne KC; Armitage NC; Hardcastle JD
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1510-1. PubMed ID: 3111616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs.
    Collins AJ; Du Toit JA
    Br J Rheumatol; 1987 Aug; 26(4):295-8. PubMed ID: 3496934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enteropathy induced by nonsteroid anti-inflammatory drugs].
    Karateev AE; Nasonova VA
    Ter Arkh; 2004; 76(2):79-82. PubMed ID: 15106423
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unsolved problems of enteropathy induced by nonsteroidal anti-inflammatory drugs].
    Murav'ev IuV; Lebedeva VV
    Ter Arkh; 2009; 81(2):90-3. PubMed ID: 19334501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiology of lesions caused by non-steroidal anti-inflammatory agents].
    De Angelis C; Rizzetto M; Pera A
    Minerva Gastroenterol Dietol; 1992; 38(1):27-40. PubMed ID: 1520751
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonsteroidal anti-inflammatory agents and gastrointestinal pathology].
    Lanas AI
    Gastroenterol Hepatol; 1995 Mar; 18(3):142-52. PubMed ID: 7621292
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
    Logan RF; Little J; Hawtin PG; Hardcastle JD
    BMJ; 1993 Jul; 307(6899):285-9. PubMed ID: 8374373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [To question the safety of non-steroid anti-inflammatory drugs].
    Verlan NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):96-8. PubMed ID: 22830108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Digestive alterations caused by non-steroideal anti-inflammatories].
    Bajador Andreu E; Pueyo Salavera CM
    Rev Esp Enferm Dig; 2004 Oct; 96(10):732. PubMed ID: 15600003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs].
    Shiokawa Y; Nobunaga M; Saito T; Asaki S; Ogawa N
    Ryumachi; 1991 Feb; 31(1):96-111. PubMed ID: 1858000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastropathy by NSAID].
    Pérez Manauta J
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():24-5. PubMed ID: 17471850
    [No Abstract]   [Full Text] [Related]  

  • 13. [When and why should we eradicate the Helicobacter pylori?].
    Perez Perez GI
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():26-7. PubMed ID: 17471851
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs).
    Simadibrata M
    Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719
    [No Abstract]   [Full Text] [Related]  

  • 15. The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs.
    Wallace JL; Cirino G
    Trends Pharmacol Sci; 1994 Nov; 15(11):405-6. PubMed ID: 7855901
    [No Abstract]   [Full Text] [Related]  

  • 16. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract.
    Barrier CH; Hirschowitz BI
    Arthritis Rheum; 1989 Jul; 32(7):926-32. PubMed ID: 2787642
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.
    MacDonald TM; Morant SV; Robinson GC; Shield MJ; McGilchrist MM; Murray FE; McDevitt DG
    BMJ; 1997 Nov; 315(7119):1333-7. PubMed ID: 9402773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of the digestive risk in patients treated with NSAIDs. Synthesis and perspectives].
    Thiéfin G; Bannwarth B
    Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C96-102. PubMed ID: 15366681
    [No Abstract]   [Full Text] [Related]  

  • 19. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects.
    Eliakim R; Rachmilewitz D
    Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.